PPD opens offices in Athens and Seattle
North Carolina, USA-based contract research firm PPD Inc has opened offices in Athens, Greece, and Seattle, Washington, as the company continues to expand its global footprint for the delivery of clinical development services in response to increasing client demand.
The company says that both offices serve as hubs for previously regional-based employees in providing development services for Phase II-IV studies in key therapeutic areas. The office in Athens focuses on patient recruitment, clinical monitoring and regulatory support while that in Seattle houses clinical monitoring and project management teams.
"The new offices enable us to address the organic growth of our business driven by client needs for Phase II-IV services as well as enhance support for our employees located in these areas," said Fred Eshelman, chief executive.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze